Exactech Reaches Consensual Agreement with Unsecured Creditors Committee, Completes Court Filing of Amended Plan

Plan Confirmation and Sale Approval Court Date Expected in Early September

GAINESVILLE, Fla., July 24, 2025 /PRNewswire/ -- Exactech, a global medical technology leader, has filed its updated plan of reorganization with the Court, having reached agreement with the Unsecured Creditors Committee (UCC) on details of a consensual plan to accompany the sale of its assets to a new ownership group. Court confirmation of the final plan and approval of the sale is anticipated in early September. 

The proposed plan was amended to include a new trust structure that will allow general unsecured claimants, including litigation plaintiffs, to continue asserting claims through the trust as it pursues recoveries from non-debtor parties. Additionally, Exactech will receive approximately $60 million of additional financing (for a total of approximately $150 million), provided by Exactech's proposed new owners, to ensure adequate funding as the company continues business as usual operations during the remainder of the proceedings.

After the Court confirms the final plan and approves the sale, the company's new owners - which include Strategic Value Partners, LLC (together with its affiliates, "SVP"), Stellex Capital Management, LLC, and Greywolf Capital Management LP - will acquire substantially all of Exactech's operations and assets free and clear, forming a new company strategically positioned for long-term success executing its mission to be the leading surgeon partner in orthopedics.

"This agreement represents a significant milestone on the path to Court approval of our plan of reorganization and emergence under new ownership," said Exactech President and CEO Darin Johnson. "We look forward to the Court's approval of the sale and confirmation of the plan over the next several weeks. Throughout this process, we have continued to develop and provide high-quality medical devices for our surgeons and their patients, and we will accelerate this progress as we emerge with a stronger foundation for long-term growth in partnership with our new owners."

David Molton, counsel for the Unsecured Creditors Committee, shared that "the UCC, in its efforts to obtain a fair recovery for claimants, appreciates the positive coordination with the new owners and management in developing a consensual plan that keeps litigation claims against certain non-debtor parties in play and, at the same time, ensures that business operations are stewarded forward under new ownership."  The UCC encourages its constituents to vote in favor of the amended plan so that the court proceedings can conclude.

SVP, Stellex and Greywolf collectively have $29 billion in assets under management and extensive operational expertise in the medical technology and device manufacturing industries.

About Exactech
Exactech is a global medical technology leader that empowers orthopaedic surgeons with innovative implants, surgical instruments and the Active Intelligence^® (AI) ecosystem of smart technologies to give patients EXACTLY what they need to regain mobility. Visit www.exac.com for more information and connect with us on LinkedIn, Vumedi, YouTube, Instagram and X.

About SVP
SVP is a global alternative investment firm that focuses on special situations, private equity, opportunistic credit and financing opportunities. The firm uses a combination of sourcing, financial and operational expertise to unlock value in its portfolio companies. Today SVP manages approximately $22 billion in assets under management, and since inception, has invested more than $50 billion of capital, including more than $18 billion in Europe. The firm, established by Victor Khosla in 2001, has over 200 employees, including more than 100 investment professionals, across its main offices in Greenwich (CT) and London, and a presence in Tokyo. Learn more at www.svpglobal.com.

About Stellex Capital Management, LLC
With offices in New York, Pittsburgh, Detroit, and London, Stellex Capital is a private equity firm with over $3.9 billion in assets under management. Stellex seeks to identify and deploy capital in opportunities that stand to benefit from its operationally focused and hands-on approach to investing. Portfolio companies are supported by Stellex's industry knowledge, operating capabilities, network of senior executives, strategic insights, and access to capital.

About Greywolf LP
Founded in 2003, Greywolf Capital Management LP ("Greywolf" or the "Firm") is a registered investment adviser with over $3 billion in assets under management allocated across our Distressed/Special Situations, CLO Credit and Hard Asset Strategies. Our accomplished and cohesive team of 32 includes 14 dedicated investment professionals. At Greywolf, we combine the expertise developed over our history with time-tested portfolio management skills to offer attractive, risk-adjusted returns over the long-term with little correlation to the broad based markets. The Firm has earned a reputation for its commitment to integrity, transparency and alignment as a true partner with our investors.

SOURCE Exactech, Inc